BioWorld

Tag Archives: EU

Biosimilars are Changing the Global Game

January 23, 2013 – 10:01 am

I recently took a few months off from daily deadlines to explore the evolving world of biosimilars for the newest BioWorld Data report, The Biosimilars Game: A Scorecard for Opportunities, Threats and Critical Strategies. It was quite an eye-opening adventure.

Share
By Mari Serebrov | Posted in Biologic, Biosimilar, emerging markets, FOB, Follow-on biologic | Also tagged , , | Comments (0)

Biotech Falls For April Fools’ Prank – Again!

April 4, 2012 – 10:41 am

The contenders for becoming the April Fool in Life Sciences for 2012 came down to three candidates, but two of them have persisted past the April 1 deadline, thereby removing themselves from consideration.

Share
By Michael Harris | Posted in Biosimilar, FDA | Also tagged , , | Comments (1)